Ruzurgi was approved last month for treating Lambert-Eaton myasthenic syndrome.
Catalyst Pharma files lawsuit against U.S. FDA on Jacobus Pharma drug approval
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain